Daniela Furrer

486 total citations
22 papers, 320 citations indexed

About

Daniela Furrer is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daniela Furrer has authored 22 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daniela Furrer's work include HER2/EGFR in Cancer Research (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Cannabis and Cannabinoid Research (3 papers). Daniela Furrer is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Cannabis and Cannabinoid Research (3 papers). Daniela Furrer collaborates with scholars based in Canada, Switzerland and United States. Daniela Furrer's co-authors include Caroline Diorio, Simon Jacob, François Sanschagrin, Louise Provencher, David Laperrière, Einas Yousef, Sylvie Mader, Muhammad Tahir, Chantal Caron and Louis Gaboury and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The FASEB Journal.

In The Last Decade

Daniela Furrer

21 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Furrer Canada 12 125 121 78 59 36 22 320
Sarah Meister Germany 13 155 1.2× 54 0.4× 30 0.4× 45 0.8× 69 1.9× 43 485
An Bracke Belgium 11 76 0.6× 201 1.7× 60 0.8× 82 1.4× 22 0.6× 15 418
Yoshiyuki Kinoshita Japan 10 108 0.9× 88 0.7× 104 1.3× 32 0.5× 31 0.9× 14 449
Beate Rautenberg Germany 7 63 0.5× 230 1.9× 65 0.8× 42 0.7× 38 1.1× 19 345
C. Soubrane France 10 123 1.0× 64 0.5× 49 0.6× 26 0.4× 18 0.5× 36 320
Edgar Vergara Mexico 9 129 1.0× 79 0.7× 39 0.5× 60 1.0× 89 2.5× 12 295
Patrick B. Thomas Australia 13 188 1.5× 85 0.7× 33 0.4× 81 1.4× 56 1.6× 29 378
Philippe Huget Belgium 6 116 0.9× 256 2.1× 27 0.3× 79 1.3× 51 1.4× 6 395

Countries citing papers authored by Daniela Furrer

Since Specialization
Citations

This map shows the geographic impact of Daniela Furrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Furrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Furrer more than expected).

Fields of papers citing papers by Daniela Furrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Furrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Furrer. The network helps show where Daniela Furrer may publish in the future.

Co-authorship network of co-authors of Daniela Furrer

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Furrer. A scholar is included among the top collaborators of Daniela Furrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Furrer. Daniela Furrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Laurin, Danielle, Caroline Sirois, Daniela Furrer, et al.. (2021). Health Impacts and Characteristics of Deprescribing Interventions in Older Adults: Protocol for a Systematic Review and Meta-analysis. JMIR Research Protocols. 10(12). e25200–e25200. 3 indexed citations
3.
Marcotte, M., Danielle Laurin, Daniela Furrer, et al.. (2021). Discontinuation of bisphosphonates in seniors: a systematic review on health outcomes. Archives of Osteoporosis. 16(1). 133–133. 11 indexed citations
4.
Furrer, Daniela, Edeltraut Kröger, M. Marcotte, et al.. (2021). Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions. SHILAP Revista de lepidopterología. 3(1). 41–41. 15 indexed citations
5.
Ennour‐Idrissi, Kaoutar, Éric Poirier, Julie Lemieux, et al.. (2021). Association of Breast Tumour Expression of Cannabinoid Receptors CBR1 and CBR2 with Prognostic Factors and Survival in Breast Cancer Patients. Journal of Personalized Medicine. 11(9). 852–852. 5 indexed citations
6.
Furrer, Daniela, et al.. (2020). Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines. PLoS ONE. 15(6). e0234991–e0234991. 21 indexed citations
7.
Furrer, Daniela, Jean‐Pierre Grégoire, Stéphane Turcotte, et al.. (2019). Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer. PLoS ONE. 14(6). e0218621–e0218621. 18 indexed citations
8.
Arias‐Reyes, Christian, et al.. (2019). NADH-linked mitochondrial respiration in the developing mouse brain is sex-, age- and tissue-dependent. Respiratory Physiology & Neurobiology. 266. 156–162. 12 indexed citations
9.
10.
Yousef, Einas, Daniela Furrer, David Laperrière, et al.. (2017). MCM2: An alternative to Ki-67 for measuring breast cancer cell proliferation. Modern Pathology. 30(5). 682–697. 64 indexed citations
11.
Furrer, Daniela, Simon Jacob, Chantal Caron, et al.. (2017). Concordance of HER2 Immunohistochemistry and Fluorescence In Situ Hybridization Using Tissue Microarray in Breast Cancer. Anticancer Research. 37(6). 3323–3329. 16 indexed citations
12.
Furrer, Daniela, Simon Jacob, Andréanne Michaud, et al.. (2017). Association of Tobacco Use, Alcohol Consumption and HER2 Polymorphisms With Response to Trastuzumab in HER2-Positive Breast Cancer Patients. Clinical Breast Cancer. 18(4). e687–e694. 8 indexed citations
13.
Furrer, Daniela, et al.. (2016). Tissue Microarray Is a Reliable Tool for the Evaluation of HER2 Amplification in Breast Cancer. Anticancer Research. 36(9). 4661–4666. 6 indexed citations
14.
15.
Diorio, Caroline, Daniela Furrer, Andréanne Michaud, et al.. (2016). Validation of EP1 Antibody Clone for Estrogen Receptor Immunohistochemistry for Breast Cancer.. PubMed. 36(1). 435–7. 3 indexed citations
16.
Furrer, Daniela, François Sanschagrin, Simon Jacob, & Caroline Diorio. (2015). Advantages and Disadvantages of Technologies for HER2 Testing in Breast Cancer Specimens: Table 1. American Journal of Clinical Pathology. 144(5). 686–703. 59 indexed citations
17.
18.
Tschuor, F., Eric Zini, Stefan Schellenberg, et al.. (2010). Remission of Diabetes Mellitus in Cats Cannot be Predicted by the Arginine Stimulation Test. Journal of Veterinary Internal Medicine. 25(1). 83–89. 14 indexed citations
19.
Furrer, Daniela, et al.. (2009). The dipeptidyl peptidase IV inhibitor NVP-DPP728 reduces plasma glucagon concentration in cats. The Veterinary Journal. 183(3). 355–357. 14 indexed citations
20.
Furrer, Daniela, K. Kaufmann, Claudia E Reusch, & Thomas A. Lutz. (2009). Amylin reduces plasma glucagon concentration in cats. The Veterinary Journal. 184(2). 236–240. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah Meister Breakdown of academic impact, for papers by An Bracke Breakdown of academic impact, for papers by Yoshiyuki Kinoshita Breakdown of academic impact, for papers by Beate Rautenberg Breakdown of academic impact, for papers by C. Soubrane Breakdown of academic impact, for papers by Edgar Vergara Breakdown of academic impact, for papers by Patrick B. Thomas Breakdown of academic impact, for papers by Philippe Huget
Rankless by CCL
2026